CHEMED CORP (CHE) Stock Fundamental Analysis
USA - NYSE:CHE - US16359R1032 - Common Stock
436.7 USD
-9.31 (-2.09%)
CHE gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 100 industry peers in the Health Care Providers & Services industry. CHE gets an excellent profitability rating and is at the same time showing great financial health properties. CHE has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
CHE had positive earnings in the past year.
CHE had a positive operating cash flow in the past year.
In the past 5 years CHE has always been profitable.
CHE had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
CHE has a Return On Assets of 17.17%. This is amongst the best in the industry. CHE outperforms 99.00% of its industry peers.
CHE has a Return On Equity of 25.89%. This is amongst the best in the industry. CHE outperforms 93.00% of its industry peers.
The Return On Invested Capital of CHE (21.28%) is better than 93.00% of its industry peers.
CHE had an Average Return On Invested Capital over the past 3 years of 21.96%. This is significantly above the industry average of 9.45%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.17% | ||
| ROE | 25.89% | ||
| ROIC | 21.28% |
ROA(3y)17.25%
ROA(5y)18.8%
ROE(3y)27.61%
ROE(5y)32.28%
ROIC(3y)21.96%
ROIC(5y)22.92%
1.3 Margins
CHE's Profit Margin of 11.02% is amongst the best of the industry. CHE outperforms 94.00% of its industry peers.
In the last couple of years the Profit Margin of CHE has grown nicely.
With an excellent Operating Margin value of 14.60%, CHE belongs to the best of the industry, outperforming 87.00% of the companies in the same industry.
CHE's Operating Margin has improved in the last couple of years.
CHE has a Gross Margin (32.88%) which is comparable to the rest of the industry.
CHE's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.6% | ||
| PM (TTM) | 11.02% | ||
| GM | 32.88% |
OM growth 3Y-0.29%
OM growth 5Y3.39%
PM growth 3Y-0.36%
PM growth 5Y1.83%
GM growth 3Y-0.79%
GM growth 5Y1.99%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CHE is creating value.
CHE has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, CHE has less shares outstanding
CHE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 12.00 indicates that CHE is not in any danger for bankruptcy at the moment.
The Altman-Z score of CHE (12.00) is better than 95.00% of its industry peers.
CHE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 12 |
ROIC/WACC2.34
WACC9.1%
2.3 Liquidity
A Current Ratio of 1.35 indicates that CHE should not have too much problems paying its short term obligations.
The Current ratio of CHE (1.35) is comparable to the rest of the industry.
A Quick Ratio of 1.33 indicates that CHE should not have too much problems paying its short term obligations.
CHE has a Quick ratio (1.33) which is comparable to the rest of the industry.
CHE does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.35 | ||
| Quick Ratio | 1.33 |
3. Growth
3.1 Past
The earnings per share for CHE have decreased by -3.97% in the last year.
Measured over the past years, CHE shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.64% on average per year.
CHE shows a small growth in Revenue. In the last year, the Revenue has grown by 6.45%.
The Revenue has been growing slightly by 4.63% on average over the past years.
EPS 1Y (TTM)-3.97%
EPS 3Y6.14%
EPS 5Y10.64%
EPS Q2Q%-6.56%
Revenue 1Y (TTM)6.45%
Revenue growth 3Y4.36%
Revenue growth 5Y4.63%
Sales Q2Q%3.09%
3.2 Future
Based on estimates for the next years, CHE will show a small growth in Earnings Per Share. The EPS will grow by 6.12% on average per year.
The Revenue is expected to grow by 5.09% on average over the next years.
EPS Next Y-3.26%
EPS Next 2Y5.47%
EPS Next 3Y6.12%
EPS Next 5YN/A
Revenue Next Year4.98%
Revenue Next 2Y5.86%
Revenue Next 3Y5.09%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
CHE is valuated rather expensively with a Price/Earnings ratio of 19.85.
Based on the Price/Earnings ratio, CHE is valued a bit cheaper than 65.00% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 25.91. CHE is valued slightly cheaper when compared to this.
CHE is valuated correctly with a Price/Forward Earnings ratio of 16.97.
Based on the Price/Forward Earnings ratio, CHE is valued a bit cheaper than the industry average as 67.00% of the companies are valued more expensively.
CHE is valuated cheaply when we compare the Price/Forward Earnings ratio to 34.57, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.85 | ||
| Fwd PE | 16.97 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CHE is on the same level as its industry peers.
67.00% of the companies in the same industry are more expensive than CHE, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.65 | ||
| EV/EBITDA | 14.68 |
4.3 Compensation for Growth
The excellent profitability rating of CHE may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.87
EPS Next 2Y5.47%
EPS Next 3Y6.12%
5. Dividend
5.1 Amount
With a yearly dividend of 0.56%, CHE is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.55, CHE pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.36, CHE's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.56% |
5.2 History
The dividend of CHE is nicely growing with an annual growth rate of 8.02%!
CHE has paid a dividend for at least 10 years, which is a reliable track record.
CHE has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)8.02%
Div Incr Years16
Div Non Decr Years21
5.3 Sustainability
CHE pays out 11.01% of its income as dividend. This is a sustainable payout ratio.
CHE's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP11.01%
EPS Next 2Y5.47%
EPS Next 3Y6.12%
NYSE:CHE (11/14/2025, 2:03:14 PM)
436.7
-9.31 (-2.09%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners98.28%
Inst Owner Change0.69%
Ins Owners1.52%
Ins Owner Change-5.81%
Market Cap6.36B
Revenue(TTM)2.53B
Net Income(TTM)278.81M
Analysts87.5
Price Target590.07 (35.12%)
Short Float %4.15%
Short Ratio3.19
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.56% |
Yearly Dividend1.83
Dividend Growth(5Y)8.02%
DP11.01%
Div Incr Years16
Div Non Decr Years21
Ex-Date
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-8.99%
Min EPS beat(2)-15.11%
Max EPS beat(2)-2.88%
EPS beat(4)1
Avg EPS beat(4)-4.45%
Min EPS beat(4)-15.11%
Max EPS beat(4)0.5%
EPS beat(8)2
Avg EPS beat(8)-3.19%
EPS beat(12)4
Avg EPS beat(12)-2.23%
EPS beat(16)8
Avg EPS beat(16)-1.06%
Revenue beat(2)0
Avg Revenue beat(2)-1.85%
Min Revenue beat(2)-2.53%
Max Revenue beat(2)-1.17%
Revenue beat(4)0
Avg Revenue beat(4)-1.07%
Min Revenue beat(4)-2.53%
Max Revenue beat(4)-0.19%
Revenue beat(8)0
Avg Revenue beat(8)-1.28%
Revenue beat(12)2
Avg Revenue beat(12)-1.05%
Revenue beat(16)2
Avg Revenue beat(16)-1.24%
PT rev (1m)0%
PT rev (3m)1.98%
EPS NQ rev (1m)2.56%
EPS NQ rev (3m)1.57%
EPS NY rev (1m)-0.01%
EPS NY rev (3m)-4.99%
Revenue NQ rev (1m)0.12%
Revenue NQ rev (3m)-0.2%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-0.27%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.85 | ||
| Fwd PE | 16.97 | ||
| P/S | 2.51 | ||
| P/FCF | 17.65 | ||
| P/OCF | 15.16 | ||
| P/B | 5.91 | ||
| P/tB | 19.59 | ||
| EV/EBITDA | 14.68 |
EPS(TTM)22
EY5.04%
EPS(NY)25.74
Fwd EY5.89%
FCF(TTM)24.74
FCFY5.66%
OCF(TTM)28.8
OCFY6.6%
SpS173.69
BVpS73.9
TBVpS22.29
PEG (NY)N/A
PEG (5Y)1.87
Graham Number191.26
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.17% | ||
| ROE | 25.89% | ||
| ROCE | 27.75% | ||
| ROIC | 21.28% | ||
| ROICexc | 23.57% | ||
| ROICexgc | 62.97% | ||
| OM | 14.6% | ||
| PM (TTM) | 11.02% | ||
| GM | 32.88% | ||
| FCFM | 14.24% |
ROA(3y)17.25%
ROA(5y)18.8%
ROE(3y)27.61%
ROE(5y)32.28%
ROIC(3y)21.96%
ROIC(5y)22.92%
ROICexc(3y)25.21%
ROICexc(5y)25.79%
ROICexgc(3y)67.33%
ROICexgc(5y)75.46%
ROCE(3y)28.73%
ROCE(5y)30.03%
ROICexgc growth 3Y-5.61%
ROICexgc growth 5Y0.34%
ROICexc growth 3Y-1.58%
ROICexc growth 5Y4.43%
OM growth 3Y-0.29%
OM growth 5Y3.39%
PM growth 3Y-0.36%
PM growth 5Y1.83%
GM growth 3Y-0.79%
GM growth 5Y1.99%
F-Score7
Asset Turnover1.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 92.02% | ||
| Cap/Sales | 2.34% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 96.74% | ||
| Profit Quality | 129.28% | ||
| Current Ratio | 1.35 | ||
| Quick Ratio | 1.33 | ||
| Altman-Z | 12 |
F-Score7
WACC9.1%
ROIC/WACC2.34
Cap/Depr(3y)89.59%
Cap/Depr(5y)94.39%
Cap/Sales(3y)2.41%
Cap/Sales(5y)2.56%
Profit Quality(3y)107.8%
Profit Quality(5y)110.23%
High Growth Momentum
Growth
EPS 1Y (TTM)-3.97%
EPS 3Y6.14%
EPS 5Y10.64%
EPS Q2Q%-6.56%
EPS Next Y-3.26%
EPS Next 2Y5.47%
EPS Next 3Y6.12%
EPS Next 5YN/A
Revenue 1Y (TTM)6.45%
Revenue growth 3Y4.36%
Revenue growth 5Y4.63%
Sales Q2Q%3.09%
Revenue Next Year4.98%
Revenue Next 2Y5.86%
Revenue Next 3Y5.09%
Revenue Next 5YN/A
EBIT growth 1Y-7.92%
EBIT growth 3Y4.05%
EBIT growth 5Y8.18%
EBIT Next Year15.23%
EBIT Next 3Y10.26%
EBIT Next 5YN/A
FCF growth 1Y39.38%
FCF growth 3Y13.77%
FCF growth 5Y8.19%
OCF growth 1Y30.35%
OCF growth 3Y10.6%
OCF growth 5Y6.75%
CHEMED CORP / CHE FAQ
What is the fundamental rating for CHE stock?
ChartMill assigns a fundamental rating of 7 / 10 to CHE.
What is the valuation status for CHE stock?
ChartMill assigns a valuation rating of 4 / 10 to CHEMED CORP (CHE). This can be considered as Fairly Valued.
Can you provide the profitability details for CHEMED CORP?
CHEMED CORP (CHE) has a profitability rating of 9 / 10.
What are the PE and PB ratios of CHEMED CORP (CHE) stock?
The Price/Earnings (PE) ratio for CHEMED CORP (CHE) is 19.85 and the Price/Book (PB) ratio is 5.91.
What is the financial health of CHEMED CORP (CHE) stock?
The financial health rating of CHEMED CORP (CHE) is 9 / 10.